41.59
price up icon1.41%   0.58
after-market Dopo l'orario di chiusura: 41.80 0.21 +0.50%
loading
Precedente Chiudi:
$41.01
Aprire:
$41.06
Volume 24 ore:
311.61K
Relative Volume:
0.75
Capitalizzazione di mercato:
$3.15B
Reddito:
$384.10M
Utile/perdita netta:
$-9.07M
Rapporto P/E:
-297.07
EPS:
-0.14
Flusso di cassa netto:
$11.10M
1 W Prestazione:
-0.19%
1M Prestazione:
+2.49%
6M Prestazione:
+49.98%
1 anno Prestazione:
+106.50%
Intervallo 1D:
Value
$40.33
$41.99
Intervallo di 1 settimana:
Value
$40.05
$42.32
Portata 52W:
Value
$17.82
$42.98

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name
Nome
Kiniksa Pharmaceuticals International Plc
Name
Telefono
(781) 431-9100
Name
Indirizzo
23 OLD BOND STREET, FLOOR 3, LONDON
Name
Dipendente
315
Name
Cinguettio
@kiniksa
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
KNSA's Discussions on Twitter

Confronta KNSA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
KNSA
Kiniksa Pharmaceuticals International Plc
41.59 3.11B 384.10M -9.07M 11.10M -0.14
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.66 51.85B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.33 45.46B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.52 42.70B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.79 34.62B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
493.99 21.03B 3.08B 1.24B 1.07B 25.61

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-29 Iniziato TD Cowen Buy
2025-03-13 Iniziato Citigroup Buy
2024-09-13 Iniziato Jefferies Buy
2024-05-03 Iniziato Wells Fargo Overweight
2020-06-29 Reiterato BofA Securities Buy
2020-04-01 Iniziato BofA/Merrill Buy
2019-03-11 Iniziato Barclays Overweight
2018-12-12 Reiterato Wedbush Outperform
2018-06-19 Iniziato JMP Securities Mkt Outperform
Mostra tutto

Kiniksa Pharmaceuticals International Plc Borsa (KNSA) Ultime notizie

pulisher
05:40 AM

Nebula Research & Development LLC Has $1.93 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

05:40 AM
pulisher
Dec 11, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells 42,841 Shares of Stock - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Kiniksa Pharma CFO Ragosa sells shares worth $1.77m By Investing.com - Investing.com Nigeria

Dec 10, 2025
pulisher
Dec 10, 2025

Jump Financial LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 10, 2025
pulisher
Dec 08, 2025

Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Walleye Capital LLC - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Arrowstreet Capital Limited Partnership Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Fisher Asset Management LLC Has $2.83 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World

Dec 06, 2025
pulisher
Dec 03, 2025

Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Traders Buy High Volume of Call Options on Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Franklin Resources Inc. Acquires 41,632 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Dec 03, 2025
pulisher
Dec 01, 2025

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 29, 2025
pulisher
Nov 28, 2025

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 28, 2025
pulisher
Nov 27, 2025

Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighTime to Buy? - MarketBeat

Nov 27, 2025
pulisher
Nov 25, 2025

AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 25, 2025
pulisher
Nov 23, 2025

200,574 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Hillsdale Investment Management Inc. - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 21, 2025
pulisher
Nov 20, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com South Africa

Nov 20, 2025
pulisher
Nov 19, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025
pulisher
Nov 18, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Jefferies London Healthcare Conference 2025Slideshow (NASDAQ:KNSA) 2025-11-18 - Seeking Alpha

Nov 18, 2025
pulisher
Nov 18, 2025

Savant Capital LLC Invests $398,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 18, 2025
pulisher
Nov 16, 2025

Mark Ragosa Sells 19,900 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Nov 16, 2025
pulisher
Nov 16, 2025

Kiniksa Rides ARCALYST Growth To Outpace The S&P 500 - Finimize

Nov 16, 2025
pulisher
Nov 14, 2025

Kiniksa Pharmaceuticals CFO Sells Shares - TradingView

Nov 14, 2025
pulisher
Nov 14, 2025

Exploring High Growth Tech Stocks in the US Market - Yahoo Finance

Nov 14, 2025
pulisher
Nov 13, 2025

Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London - The Manila Times

Nov 13, 2025
pulisher
Nov 12, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Increases 5.3% This Week, Taking Five-year Gains to 166% - 富途牛牛

Nov 12, 2025
pulisher
Nov 12, 2025

Kiniksa (NASDAQ: KNSA) to present at Jefferies Healthcare Conf.; live webcast Nov. 17 - Stock Titan

Nov 12, 2025
pulisher
Nov 11, 2025

Connor Clark & Lunn Investment Management Ltd. Has $17.26 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 11, 2025
pulisher
Nov 11, 2025

Kiniksa Pharmaceuticals International, plc $KNSA Shares Acquired by Acadian Asset Management LLC - MarketBeat

Nov 11, 2025
pulisher
Nov 09, 2025

Fox Run Management L.L.C. Buys 24,391 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 09, 2025
pulisher
Nov 06, 2025

Vanguard Group Inc Reduces Stake in Kiniksa Pharmaceuticals Inte - GuruFocus

Nov 06, 2025

Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
Capitalizzazione:     |  Volume (24 ore):